![]() ![]() and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. #BEEM STOCK FORECAST 2021 LICENSE#license agreement with Sana Biotechnology, Inc. #BEEM STOCK FORECAST 2021 TRIAL#The company has an alliance with Boston Children's Hospital a research and clinical trial collaboration agreement with Magenta Therapeutics, Inc. It also develops therapies for alpha-1 antitrypsin deficiency ocular diseases and other liver, muscle, and central nervous system disorders. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia BEAM-102 for the treatment of sickle cell disease and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia and BEAM-301, a liver-targeted development candidate for the treatment of patients with Glycogen Storage Disease Type Ia. ![]() This signified a fall of nearly 14.27%.īesides this sudden fall, the stock has performed well in the past month, and the demand for electric vehicles could propel the company further ahead.Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. On April 20, the stock opened at $22.14 and closed at $18.98. On a single day, the stock price decreased substantially. Recently, however, the stock has reverted to a downturn. Experts have also named BEEM, among other stocks, as the top selection for a potential short squeeze. What else is on the Menu?Ĭonsidering BEEM’s stock data of the past multiple years, the stock has risen by a whopping 169.22% in the past five years.Įarlier the company unmasked its financial highlights for 2021, setting a new record for annual revenues when it reported $9.0 million in revenue for the year. The system would be used to power electric vehicles that are part of the city’s fleet, including an electric shuttle bus for the city’s Senior Center. ![]() Much of this can be attributed to a March 17 announcement that Beam had deployed a clean charging system for Costa Mesa, a city in California, where the company itself is headquartered. In a plot twist, BEEM closed at $20.45 the same day a stunning rise of almost 13.11%. Its lowest value was on January 27, but later the stock rebounded. Total shares on loan are around 2.36 million, and the short interest rate is at 27.4%.īEEM started the year with a closing price of $20.17, which later dropped significantly until March. #BEEM STOCK FORECAST 2021 FULL#As of April 19, the utilization rate is standing at a full 100%, as it has been since February 07. Until now, the whole of 2022 has been a roller coaster ride for BEEM. But recent events in 2022 prove that there is still hope for the stock through the trends of a short squeeze. True to it, the stock took a startling downturn. Later in 2021, multiple insiders at Beam Global began selling their shares in the company in large numbers. This turn in value was partly because Beam welcomed new patents for its EV charging framework. In the past couple of years, BEEM saw its highest stock rise at the end of 2020 and the beginning of 2021. ![]() The company came to be in 2006 and, has a current M Cap of $190.46 million. A Capital Goods company headquartered in California, Beam Global (BEEM: US) designs and mass-manufactures products that focus on sustainable transportation and clean technology. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |